Heart Outcomes Prevention Evaluation "HOPE"

Completed

Phase N/A Results

Summary of Purpose

To investigate the efficacy of an ACE inhibitor (ramipril) and vitamin E in improving the long-term outcome of patients at high risk for cardiovascular events.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 December 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Canadian Institutes for Health Research, Aventis, AstraZeneca, King Pharmaceuticals, Natural Source Vitamin E Association, Negma, Heart and Stroke Foundation of Ontario

Trial Design

Randomized, multicenter, double-blind, placebo-controlled, three-by-two factorial study

Contacts

Not available